The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 6 to 18 months of age.
Official Title
Conditions
– Bronchiolitis
Study Type
Interventional
Study Design
Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Further Details
Study Start
Eligibility & Criteria
Ages Eligible for Study: 6 Months – 18 Months, Genders Eligible for Study: Both Criteria Hospitalized at least 24 hours for a first episode of RSV-induced bronchiolitis
Total Enrolment
Contact Details
[1] Sponsor Name PendingAll content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
